Ectopic ACTH Syndrome: Clinical Trials

3 trials for Ectopic ACTH Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Terminated 1, Withdrawn 1
Phase 11Completed 1

Follow Ectopic ACTH Syndrome: new trials by email Literature Review of Ectopic ACTH Syndrome trials Research Report on Ectopic ACTH Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
atumelnant - Cushing Syndrome, Cushing Disease
Phase 1 / Phase 2CompletedCrinetics Pharmaceuticals Inc.192023-10-122026-10-14
SOM230 Ectopic ACTH-producing Tumors
Pasireotide - Ectopic ACTH Syndrome
Phase 2WithdrawnCedars-Sinai Medical Center2015-12-012018-01-26
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
pasireotide LAR - Pancreatic Neoplasm, Pituitary Neoplasm
Phase 2TerminatedNovartis Pharmaceuticals1182009-09-012016-07-26

Narrower conditions

ACTH Syndrome, Ectopic (3)  ·  Cushing Syndrome (1)  ·  Nelson Syndrome (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Pancreatic Neoplasms (1)  ·  Pituitary ACTH Hypersecretion (1)  ·  Pituitary Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Paraneoplastic Endocrine Syndromes (3)  ·  Paraneoplastic Syndromes (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Endocrine System Diseases (2)  ·  Hypothalamic Diseases (2)  ·  Nervous System Diseases (2)  ·  Pituitary Diseases (2)  ·  ACTH-Secreting Pituitary Adenoma (1)  ·  Adrenal Gland Diseases (1)  ·  Adrenocortical Hyperfunction (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Digestive System Diseases (1)

Interventions

pasireotide (2)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Crinetics Pharmaceuticals Inc. (1)  ·  Novartis Pharmaceuticals (1)

Countries

United States (3)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Russia (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Ning-Ai Liu, MD, PhD (1)

NIH funding

2008 (1)